Journal of Personalized Medicine最新文献

筛选
英文 中文
Correction: Islam et al. Exploring the Immunological Role of the Microbial Composition of the Appendix and the Associated Risks of Appendectomies. J. Pers. Med. 2025, 15, 112. 更正:伊斯兰教等。探讨阑尾微生物组成的免疫学作用及阑尾切除术的相关风险。j·珀耳斯。医学,2025,15,112。
IF 3 3区 医学
Journal of Personalized Medicine Pub Date : 2026-11-06 DOI: 10.3390/jpm16110573
Tarequl Islam, Md Shahjalal Sagor, Noshin Tabassum Tamanna, Md Kamrul Islam Bappy, Danishuddin, Md Azizul Haque, Maximilian Lackner
{"title":"Correction: Islam et al. Exploring the Immunological Role of the Microbial Composition of the Appendix and the Associated Risks of Appendectomies. <i>J. Pers. Med.</i> 2025, <i>15</i>, 112.","authors":"Tarequl Islam, Md Shahjalal Sagor, Noshin Tabassum Tamanna, Md Kamrul Islam Bappy, Danishuddin, Md Azizul Haque, Maximilian Lackner","doi":"10.3390/jpm16110573","DOIUrl":"https://doi.org/10.3390/jpm16110573","url":null,"abstract":"<p><p>There were errors in the original publication [...].</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"16 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RETRACTED: Inchingolo et al. Precision Medicine on the Effects of Microbiota on Head-Neck Diseases and Biomarkers Diagnosis. J. Pers. Med. 2023, 13, 933. 撤稿:Inchingolo et al。微生物群在头颈部疾病和生物标志物诊断中的作用的精准医学。j·珀耳斯。医学,2023,13,933。
IF 3 3区 医学
Journal of Personalized Medicine Pub Date : 2026-10-30 DOI: 10.3390/jpm16110562
Angelo Michele Inchingolo, Giuseppina Malcangi, Fabio Piras, Giulia Palmieri, Vito Settanni, Lilla Riccaldo, Roberta Morolla, Silvio Buongiorno, Elisabetta de Ruvo, Alessio Danilo Inchingolo, Antonio Mancini, Francesco Inchingolo, Gianna Dipalma, Stefania Benagiano, Gianluca Martino Tartaglia, Assunta Patano
{"title":"RETRACTED: Inchingolo et al. Precision Medicine on the Effects of Microbiota on Head-Neck Diseases and Biomarkers Diagnosis. <i>J. Pers. Med.</i> 2023, <i>13</i>, 933.","authors":"Angelo Michele Inchingolo, Giuseppina Malcangi, Fabio Piras, Giulia Palmieri, Vito Settanni, Lilla Riccaldo, Roberta Morolla, Silvio Buongiorno, Elisabetta de Ruvo, Alessio Danilo Inchingolo, Antonio Mancini, Francesco Inchingolo, Gianna Dipalma, Stefania Benagiano, Gianluca Martino Tartaglia, Assunta Patano","doi":"10.3390/jpm16110562","DOIUrl":"10.3390/jpm16110562","url":null,"abstract":"<p><p>The journal retracts the article titled \"Precision Medicine on the Effects of Microbiota on Head-Neck Diseases and Biomarkers Diagnosis\" [...].</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"16 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13721833/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RETRACTED: Patano et al. Mandibular Crowding: Diagnosis and Management-A Scoping Review. J. Pers. Med. 2023, 13, 774. 撤稿:Patano et al。下颌拥挤:诊断和管理:一个范围回顾。j·珀耳斯。医学,2023,13,774。
IF 3 3区 医学
Journal of Personalized Medicine Pub Date : 2026-10-23 DOI: 10.3390/jpm16110542
Assunta Patano, Giuseppina Malcangi, Alessio Danilo Inchingolo, Grazia Garofoli, Nicole De Leonardis, Daniela Azzollini, Giulia Latini, Antonio Mancini, Vincenzo Carpentiere, Claudia Laudadio, Francesco Inchingolo, Silvia D'Agostino, Daniela Di Venere, Gianluca Martino Tartaglia, Marco Dolci, Gianna Dipalma, Angelo Michele Inchingolo
{"title":"RETRACTED: Patano et al. Mandibular Crowding: Diagnosis and Management-A Scoping Review. <i>J. Pers. Med.</i> 2023, <i>13</i>, 774.","authors":"Assunta Patano, Giuseppina Malcangi, Alessio Danilo Inchingolo, Grazia Garofoli, Nicole De Leonardis, Daniela Azzollini, Giulia Latini, Antonio Mancini, Vincenzo Carpentiere, Claudia Laudadio, Francesco Inchingolo, Silvia D'Agostino, Daniela Di Venere, Gianluca Martino Tartaglia, Marco Dolci, Gianna Dipalma, Angelo Michele Inchingolo","doi":"10.3390/jpm16110542","DOIUrl":"10.3390/jpm16110542","url":null,"abstract":"<p><p>The journal retracts the review article titled \"Mandibular Crowding: Diagnosis and Management-A Scoping Review\" [...].</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"16 11","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149322349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advanced MR Technique for the Prediction of a Complete Response Following Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Comparative Study Between DWI b2000 and b1000. 预测局部晚期直肠癌患者新辅助放化疗后完全缓解的先进MR技术:DWI b2000和b1000的比较研究
IF 3 3区 医学
Journal of Personalized Medicine Pub Date : 2026-10-21 DOI: 10.3390/jpm16100537
Geon Lee, Seung Ho Kim, Mingyu Kim, Dajung Kim, Hye Ri Kim
{"title":"Advanced MR Technique for the Prediction of a Complete Response Following Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Comparative Study Between DWI <i>b</i>2000 and <i>b</i>1000.","authors":"Geon Lee, Seung Ho Kim, Mingyu Kim, Dajung Kim, Hye Ri Kim","doi":"10.3390/jpm16100537","DOIUrl":"10.3390/jpm16100537","url":null,"abstract":"<p><p><b>Background/Objectives</b>: From the viewpoint of personalized medicine, it is important to properly select patients with a complete response (CR) after neoadjuvant chemoradiotherapy (nCRT) because they are candidates for \"watch-and-wait\" management in locally advanced rectal cancer (LARC). The aims of this study were to evaluate the added value of diffusion-weighted imaging (DWI) <i>b</i>2000 to high-resolution T2-weighted images (HR-T2WI) and to compare the diagnostic performance of DWI <i>b</i>2000 and <i>b</i>1000 for assessing a CR in patients with LARC after nCRT. <b>Methods</b>: This retrospective study included 55 patients (male: 40, female: 15; mean age: 60.1) who underwent pre- and post-nCRT 3T MRI, including DWI<sub>b1000</sub> and DWI<sub>b2000</sub>. Two blinded radiologists independently assessed the likelihood of a CR using a five-point scale across three image sets: T2-weighted images (T2WI), T2WI + DWI<sub>b1000</sub>, and T2WI + DWI<sub>b2000</sub>. T2WI were provided because DWI is not used as a standalone sequence in clinical practice when evaluating the therapeutic response to nCRT. A crossover review of DWI<sub>b1000</sub> and DWI<sub>b2000</sub> with a four-week interval was used to minimize recall bias. The reference standard of a CR was histopathologic examination or clinical remission in cases of watch-and-wait management. For each reader, diagnostic performance was compared across three image sets using pairwise comparisons of the receiver operating characteristic (ROC) curves. <b>Results</b>: The study population comprised 19 patients with a CR and 36 patients with residual tumor. For both readers, adding DWI<sub>b2000</sub> significantly enhanced diagnostic performance compared to T2WI alone (AUC for reader 1: 0.918, 0.806, <i>p</i> = 0.0288; AUC for reader 2: 0.868, 0.768, <i>p</i> = 0.0414, respectively), likewise, DWI<sub>b1000</sub> (for reader 1: 0.955, <i>p</i> = 0.0015; for reader 2: 0.863, <i>p</i> = 0.0162). However, no significant difference in diagnostic performance was found between DWI<sub>b1000</sub> and DWI<sub>b2000</sub> for each reader (for reader 1: <i>p</i> = 0.0931; for reader 2: <i>p</i> = 0.8936). <b>Conclusions</b>: Adding DWI<sub>b2000</sub> to T2WI improved diagnostic performance for identifying a CR after nCRT compared to T2WI alone. No statistical difference was detected between DWI<sub>b1000</sub> and DWI<sub>b2000</sub>.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"16 10","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13705676/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149269281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Multidisciplinary Teams Are Reshaping Adult IBD Management: A Narrative Review. 多学科团队如何重塑成人IBD管理:叙述性回顾。
IF 3 3区 医学
Journal of Personalized Medicine Pub Date : 2026-10-21 DOI: 10.3390/jpm16100536
Alessia Todeschini, Maria Vittoria Teso, Giuliano Barugola, Angela Variola
{"title":"How Multidisciplinary Teams Are Reshaping Adult IBD Management: A Narrative Review.","authors":"Alessia Todeschini, Maria Vittoria Teso, Giuliano Barugola, Angela Variola","doi":"10.3390/jpm16100536","DOIUrl":"10.3390/jpm16100536","url":null,"abstract":"<p><p>Current guidelines strongly endorse integrated multidisciplinary team (MDT) approaches to manage the complexity of patients with IBD. Evidence from formal multidisciplinary case discussions suggests an impact on diagnostic and treatment decisions, while studies of broader integrated IBD services report associations with improved disease control, quality of life, and healthcare utilization. However, implementation remains heterogeneous across centers, with variability in team composition, meeting frequency, referral criteria, and access to specialist services. Future directions include standardization of MDT composition and processes, definition of quality indicators, extension of specialist expertise through hub-and-spoke networks and telemedicine, and integration of patients as active partners in care. Digital tools may support communication and remote follow-up, whereas the role of artificial intelligence in MDT decision-making remains investigational and requires clinical validation. Multidisciplinary care should be regarded as a core organizational principle of modern IBD management. Realizing its full potential will require sustained investment, workforce planning, and prospective research to ensure equitable, high-quality, and sustainable care across diverse healthcare settings.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"16 10","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13705887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149269326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Techniques and Emerging Technologies in Chronic Total Occlusion Percutaneous Coronary Intervention: A Structured, Narrative Review. 慢性全闭塞经皮冠状动脉介入治疗的新技术和新兴技术:一篇结构化的叙述性综述。
IF 3 3区 医学
Journal of Personalized Medicine Pub Date : 2026-10-21 DOI: 10.3390/jpm16100538
Michał Dobrzyński, Paweł Warzyszak, Bartosz Zięba
{"title":"Novel Techniques and Emerging Technologies in Chronic Total Occlusion Percutaneous Coronary Intervention: A Structured, Narrative Review.","authors":"Michał Dobrzyński, Paweł Warzyszak, Bartosz Zięba","doi":"10.3390/jpm16100538","DOIUrl":"10.3390/jpm16100538","url":null,"abstract":"<p><p>Chronic total occlusions (CTOs) represent one of the most technically demanding areas of percutaneous coronary intervention (PCI). Despite advances in equipment and operator expertise, CTO PCI remains associated with lower procedural success rates and a higher risk of complications than non-CTO PCI. This review summarizes emerging techniques and technologies designed to improve procedural efficiency, safety, and outcomes in contemporary, personalized patient care. Recent innovations span multiple domains of CTO PCI. The minimalistic hybrid approach (MHA) aims to reduce vascular complications by minimizing the number of access sites and the sheath size. Novel perforation management strategies, including the cut balloon technique (CBT) and the condom technique, offer simple, low-cost options for distal vessel sealing, supported so far only by small series and technical reports. Advanced re-entry methods, such as tip-detection, antegrade dissection and re-entry (TD-ADR), integrate intravascular ultrasound (IVUS) to enhance precision. HydroDynamic contrast recanalization (HDR) revisits hydraulic dissection with a controlled, microcatheter-based contrast strategy whose safety profile remains to be established. The microcatheter anchor technique (MAT) has been proposed to facilitate retrograde CTO PCI in post-CABG anatomy. New plaque-modifying strategies, including RODIN-CUT and ORCAS, leverage high-pressure cutting balloon inflations under real-time IVUS guidance. Additional technologies, such as Plasmawire™, Shockwave Javelin<sup>®</sup>, and Hertz Contact intravascular lithotripsy (IVL), may expand the armamentarium for crossing and modifying complex CTO lesions, although CTO-specific clinical data are very limited (for Javelin, a 20-patient first-in-human coronary series). CT coronary angiography (CTCA) continues to improve pre-procedural planning, while drug-coated balloons (DCBs) show promise in selected de novo CTO lesions, although the evidence remains limited to retrospective series. Taken together, this rapid pace of innovation is steadily widening the procedural toolkit available for CTO PCI and may improve outcomes. Evidence for most of these techniques comes from case reports, small single-center series, and early-phase single-arm studies. It suggests feasibility in selected patients, but safety data are limited, and some reports signal concerns, including tamponade after the cut balloon technique and a higher perforation rate in a registry of the Carlino technique. The place of these techniques in routine practice will become clear only once larger, multicenter trials are completed.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"16 10","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706605/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149269403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Same Hospital, Different Outcome: In-Hospital Mortality and Divergent Prognostic Associations in Jewish and Arab Patients with Acute Ischemic Stroke in Northern Israel. 同一家医院,不同的结果:以色列北部犹太裔和阿拉伯裔急性缺血性卒中患者的住院死亡率和不同的预后关联
IF 3 3区 医学
Journal of Personalized Medicine Pub Date : 2026-10-20 DOI: 10.3390/jpm16100535
Chen Hanna Ryder, Yazid Badarny, Carmit Gal, Gili Barkay, Einav Levy, Rima Nassar, Samih Badarny, Radi Shahien
{"title":"Same Hospital, Different Outcome: In-Hospital Mortality and Divergent Prognostic Associations in Jewish and Arab Patients with Acute Ischemic Stroke in Northern Israel.","authors":"Chen Hanna Ryder, Yazid Badarny, Carmit Gal, Gili Barkay, Einav Levy, Rima Nassar, Samih Badarny, Radi Shahien","doi":"10.3390/jpm16100535","DOIUrl":"10.3390/jpm16100535","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Individualized risk estimation after stroke depends on prognostic models, which may not transfer between populations. Jewish and Arab patients with acute stroke in the Western Galilee share one regional center and its protocols. We examined whether mortality, prognostic associations of admission variables and pooled-model calibration differ between them. <b>Methods:</b> This retrospective single-center cohort study included adults with non-lacunar acute ischemic stroke and moderate or greater vessel occlusion admitted to the Galilee Medical Center, Israel, from March 2023 to February 2025. The outcome was in-hospital death. Mortality was compared before and after adjustment for age, sex and stroke severity, and prognostic heterogeneity was tested with interaction terms in Firth penalized regression. <b>Results:</b> Of 499 patients, 289 were Jewish and 210 Arab; Jewish patients were older (mean 72.1 versus 67.5 years) and less often current smokers, with similar sex distribution and stroke severity. Mortality was 11.1% in Jewish and 4.8% in Arab patients (risk ratio 2.33, 95% confidence interval (CI) 1.17 to 4.62; adjusted odds ratio 2.05, 95% CI 0.97 to 4.34). In a joint test of age, sex and C-reactive protein (CRP), prognostic associations differed between groups (<i>p</i> = 0.012), mainly because CRP was more weakly associated with death in Jewish patients; white blood cell count showed a similar exploratory pattern. A pooled model without a group term tended to underpredict deaths in Jewish and overpredict them in Arab patients. <b>Conclusions:</b> Within one stroke service, mortality and the prognostic weight of admission variables differed between population groups. These exploratory findings require replication and, if confirmed, would support population-aware validation and recalibration of prognostic models. They concern risk estimation, not treatment, which should follow the same criteria in both groups.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"16 10","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13705706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149269320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Menin Inhibitors in Acute Myeloid Leukemia: From Molecular Rationale to Clinical Practice. 急性髓系白血病的Menin抑制剂:从分子原理到临床实践。
IF 3 3区 医学
Journal of Personalized Medicine Pub Date : 2026-10-19 DOI: 10.3390/jpm16100534
Caterina Alati, Matteo Molica, Martina Pitea, Gaetana Porto, Violetta Marafioti, Laura Giordano, Laura De Fazio, Marco Rossi, Massimo Martino
{"title":"Menin Inhibitors in Acute Myeloid Leukemia: From Molecular Rationale to Clinical Practice.","authors":"Caterina Alati, Matteo Molica, Martina Pitea, Gaetana Porto, Violetta Marafioti, Laura Giordano, Laura De Fazio, Marco Rossi, Massimo Martino","doi":"10.3390/jpm16100534","DOIUrl":"10.3390/jpm16100534","url":null,"abstract":"<p><p><b>Background</b>: Acute Myeloid Leukemia (AML) harboring KMT2A rearrangements (KMT2Ar) or NPM1 mutations (mNPM1) constitutes a substantial and molecularly coherent subset of AML characterized by aberrant activation of homeobox (HOX) gene programs driven by the menin-MLL transcriptional complex. Disruption of this interaction through small-molecule menin inhibitors represents a compelling therapeutic strategy. <b>Methods</b>: We conducted a narrative (non-systematic) review of the clinical literature on four menin inhibitors-revumenib, ziftomenib, bleximenib, and enzomenib-as monotherapy and in combination regimens, identified through PubMed/MEDLINE and conference abstract searches (ASH, EHA) without a pre-specified systematic search protocol, as detailed in the Introduction. <b>Results</b>: Revumenib received FDA approval in November 2024 for relapsed/refractory (R/R) acute leukemia with a KMT2A translocation (an indication not restricted by lineage; the pivotal cohort included AML, ALL and MPAL), demonstrating a CR + CRh rate of 21.2% in the pivotal AUGMENT-101 trial, and a second FDA approval followed in October 2025 for R/R mNPM1 AML. In R/R mNPM1 AML (cohort 2C), an overall response rate (ORR) of 46.9% was observed. Ziftomenib achieved its primary phase II endpoint in R/R mNPM1 AML (CR/CRh 23%, <i>p</i> = 0.0058 vs. historical control) and received FDA approval (as Komzifti) in November 2025 for the same indication. Combination strategies with venetoclax/azacitidine have shown high response rates in small, non-randomized newly diagnosed cohorts (ORR approximately 88-94%), although the contribution of the menin inhibitor cannot be established without randomized data. Bleximenib and enzomenib show similarly encouraging early-phase signals. Resistance via acquired MEN1 mutations (M327I/V, G331R/D, T349M) has been identified in approximately 38.7% of revumenib-treated patients who progress after two or more cycles. Differentiation syndrome remains the most characteristic class-specific toxicity, occurring in approximately 11-28% of patients across agents (rates vary by cohort, data cut and prophylaxis strategy). <b>Conclusions</b>: Menin inhibitors represent a clinically important addition to the treatment of KMT2A- and mNPM1-driven AML, following the precedent set by FLT3 and IDH inhibitors. Combination approaches with hypomethylating agents and BCL-2 inhibition show particular promise, although no randomized controlled trial has yet demonstrated a survival benefit and current evidence derives predominantly from single-arm, early-phase studies. Ongoing randomized trials will define the definitive role of these agents across disease settings.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"16 10","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13705857/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149269382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond Mallampati: From Universal Bedside Tests to Precision Airway Risk Stratification. 超越Mallampati:从通用床边测试到精确气道风险分层。
IF 3 3区 医学
Journal of Personalized Medicine Pub Date : 2026-10-16 DOI: 10.3390/jpm16100532
Daniele Salvatore Paternò, Luigi La Via, Flavia Paola Arena, Francesca Barbagallo, Basilio Davide Lesina Calà, Emilia Concetta Lo Giudice, Rita Cataldo, Massimiliano Sorbello
{"title":"Beyond Mallampati: From Universal Bedside Tests to Precision Airway Risk Stratification.","authors":"Daniele Salvatore Paternò, Luigi La Via, Flavia Paola Arena, Francesca Barbagallo, Basilio Davide Lesina Calà, Emilia Concetta Lo Giudice, Rita Cataldo, Massimiliano Sorbello","doi":"10.3390/jpm16100532","DOIUrl":"10.3390/jpm16100532","url":null,"abstract":"<p><p>Airway management remains one of the few domains of anaesthetic practice still governed by universal, dichotomous screening thresholds applied to profoundly heterogeneous populations. Conventional bedside tests-the modified Mallampati test, thyromental distance and the upper lip bite test-retain modest and inconsistent diagnostic accuracy, leaving the majority of difficult intubations unanticipated while generating false alarms that drive resource-intensive contingency plans. This narrative review reframes preoperative airway evaluation as a problem of individualised risk stratification rather than population screening. We first summarise the performance limits of classical bedside predictors and the reasons for their ceiling effect, including low target prevalence, inter-observer variability, spectrum bias and heterogeneous outcome definitions. We then examine the data streams reshaping the field: point-of-care upper airway ultrasound, whose parameters provide operator-accessible and objective anatomical information; cross-sectional and craniofacial imaging; and machine-learning models based on clinical variables, facial images and voice analysis. For each we discuss accuracy, reproducibility, validation status and barriers to adoption. We then propose a phenotype-oriented framework in which assessment intensity is matched to pre-test probability, with dedicated pathways for obesity and obstructive sleep apnoea, obstetric, head-and-neck oncological and post-radiotherapy, critically ill and emergency, and paediatric populations. We map this framework onto the 2025 European Society of Anaesthesiology and Intensive Care and Difficult Airway Society recommendations and outline the validation, calibration and equity requirements-including algorithmic bias across skin tone, sex and ethnicity-that must be met before precision airway assessment can enter routine practice.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"16 10","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149269310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal, Phenotypic, and Treatment-Context Heterogeneity in Retinal Vasculitis Reporting with Pegcetacoplan: A United States Pharmacovigilance Study. 美国一项药物警戒研究:佩西可平报告视网膜血管炎的时间、表型和治疗背景异质性。
IF 3 3区 医学
Journal of Personalized Medicine Pub Date : 2026-10-16 DOI: 10.3390/jpm16100533
Siddharth Gandhi, Michael Balas, Patrick Wang, Parnian Arjmand
{"title":"Temporal, Phenotypic, and Treatment-Context Heterogeneity in Retinal Vasculitis Reporting with Pegcetacoplan: A United States Pharmacovigilance Study.","authors":"Siddharth Gandhi, Michael Balas, Patrick Wang, Parnian Arjmand","doi":"10.3390/jpm16100533","DOIUrl":"10.3390/jpm16100533","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Pegcetacoplan slows geographic atrophy (GA) progression, but postmarketing retinal vasculitis remains an important safety concern. We evaluated whether retinal vasculitis reporting changed over time, whether the reported phenotype changed with respect to occlusive coding, and whether vasculitis was associated with identifiable treatment contexts. <b>Methods:</b> We analyzed the United States (US) Food and Drug Administration Adverse Event Reporting System (FAERS) data from 17 February 2023 through 31 December 2025. Strict retinal vasculitis reports required pegcetacoplan to be coded as the primary-suspect drug. Faricimab was used as a descriptive contemporaneous intravitreal comparator because US exposure estimates could be constructed over the same period; it was not treated as a safety-neutral control. Separately, within all US primary-suspect Syfovre reports, we examined whether another anti-vascular endothelial growth factor (anti-VEGF) agent was co-reported. These anti-VEGF agents were evaluated as treatment-context variables rather than as temporal comparators. <b>Results:</b> We identified 79 US primary-suspect Syfovre retinal vasculitis reports, of which 58 had quarter-assignable clinical event dates. Overall, 42/79 (53.2%) contained an occlusive-specific vasculitis preferred term and 37/79 (46.8%) did not. Pegcetacoplan reporting declined from 4.09 to 0.38 reports per 10,000 estimated vials between the pre-change and post-change periods (reporting-rate ratio 0.09, 95% confidence interval [CI] 0.05-0.16; <i>p</i> < 0.001). Faricimab reporting also declined; the ratio of reporting-rate ratios was 0.79 (95% CI 0.22-2.78; <i>p</i> = 0.711), with wide uncertainty. Among temporally assignable pegcetacoplan reports, occlusive-specific coding decreased from 16/21 (76.2%) before the change to 8/30 (26.7%) afterward (<i>p</i> < 0.001). Another anti-VEGF agent was listed in 19/79 vasculitis reports versus 50/571 nonvasculitis reports (reporting odds ratio 3.30, 95% CI 1.83-5.96; <i>p</i> < 0.001); however, adjustment for medication count and report completeness attenuated the estimate to 1.89 (95% CI 0.99-3.61; <i>p</i> = 0.052). <b>Conclusions:</b> Pegcetacoplan retinal vasculitis reporting declined over time, but the descriptive faricimab comparison was too imprecise to determine whether the proportional temporal change differed between products. The reported phenotype shifted away from occlusive-specific coding, while the anti-VEGF co-reporting association was sensitive to adjustment for documentation intensity. These findings characterize heterogeneity in spontaneous safety reporting and do not establish patient-level risk, changes in clinical event severity, or causal treatment effects.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"16 10","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13705734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149269351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书